Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Sell
8,827
-10,473
-54% -$1.88M 0.01% 1118
2025
Q4
$3.49M Buy
19,300
+9,392
+95% +$1.78M 0.02% 626
2025
Q3
$1.87M Sell
9,908
-243
-2% -$42.3K 0.01% 784
2025
Q2
$1.61M Buy
10,151
+552
+6% +$81.6K 0.01% 762
2025
Q1
$1.27M Buy
9,599
+1,967
+26% +$275K 0.01% 727
2024
Q4
$1.12M Buy
7,632
+2,204
+41% +$367K 0.01% 722
2024
Q3
$885K Buy
+5,428
New +$821K 0.02% 611

Other funds holding LDOS

&Partners's LDOS Position: Q1 2026 in Review

&Partners reduced its Leidos (LDOS) stake by 54% in Q1 2026, selling an estimated $1.88M and leaving 8,827 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #1118.

&Partners first reported a position in LDOS in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.49M in Q4 2025. 897 funds tracked by Wall St. Rank hold LDOS as of Q1 2026.

  • &Partners held 8,827 shares of Leidos worth $1.37M as of Q1 2026.
  • &Partners sold 10,473 Leidos shares in Q1 2026, an estimated $1.88M.
  • Leidos made up 0.01% of &Partners's portfolio in Q1 2026, its #1118 holding.
  • &Partners first reported a position in Leidos in Q3 2024 and has held it in 7 quarters since.
  • &Partners's Leidos position peaked at $3.49M in Q4 2025.
  • 897 funds tracked by Wall St. Rank held Leidos as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.